Significant Ownership of GREAT POINT PARTNERS LLC

Notable people
Dr. Jeffrey R. Jay, Mr. David Kroin, Ortav Yehudai, Lillian Nordahl
Signature - Title
/s/ Dr. Jeffrey R. Jay, M.D - Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GREAT POINT PARTNERS LLC.

Notify me when GREAT POINT PARTNERS LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of GREAT POINT PARTNERS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 9.99% $7.23M 11.5M Great Point Partners, LLC 31 Dec 2024
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 9.99% $2.55M $1.13M 5.97M +79.1% Great Point Partners, LLC 30 Sep 2025
VTGN Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share 6.28% $7.3M 2.06M 0% Great Point Partners, LLC 30 Sep 2025
Inventiva S.A. Ordinary shares, nominal value 0.01 Euro per share 6.06% 8.64M -18.3% Great Point Partners, LLC 30 Sep 2025
ZURA Zura Bio Ltd Class A Ordinary Shares 5.87% $16.5M $2.8M 3.82M +20.4% Great Point Partners, LLC 30 Sep 2025
VOR VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share 5.63% $9.83M 1.23M Great Point Partners, LLC 10 Dec 2025
CNTX Context Therapeutics Inc. Common Stock 5.22% $4.54M 4.68M 0% Great Point Partners, LLC 30 Sep 2025
OTLK Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share 4.99% $4.48M 2.22M 0% Great Point Partners, LLC 30 Jun 2025
OPTN OPTINOSE, INC. Common Stock, $0.001 par value per share 4.94% $4.79M -$3.37M 526K -41.3% Great Point Partners, LLC 31 Mar 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 4.51% $3.47M 797K 0% Great Point Partners, LLC 30 Sep 2025
NGNE NEUROGENE INC. Common Stock, par value $0.000001 per share 2.98% $6.82M 443K Great Point Partners, LLC 31 Dec 2024

Schedules 13D/G Reported by GREAT POINT PARTNERS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.